Afelimomab
Afelimomab (MAK 195F) is an anti-tumor necrosis factor monoclonal antibody. Afelimomab can be used for the research of sepsis[1].
Product Specifications
CAS Number
156227-98-4
Product Name Alternative
MAK 195F
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/afelimomab.html
Purity
99.34
Solubility
10 mM in DMSO
Smiles
[Afelimomab]
Molecular Weight
(145.82 kDa)
References & Citations
[1]Edward A Panacek, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F (ab') 2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004 Nov;32 (11) :2173-82.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx596589 96 Tests
Neural Retina Leucine Zipper (NRL) DNA-Binding ELISA Kit
Sign In for Pricing
View Details 